IDiyas

For the Inventor, By the Inventor

Rancho Santa Margarita, CA, United States of America

Franklin Quan

USPTO Granted Patents = 15 

Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Laguna Niguel, CA (US) (2010 - 2013)
  • Rancho Santa Margarita, CA (US) (2010 - 2022)

Company Filing History:

goldMedal15 out of 479 
 
Quest Diagnostics Investments, Inc.
 patents

Years Active: 2010-2022

Loading Chart...
15 patents (USPTO):Explore Patents
1. 11447826 - Cystic fibrosis transmembrane conductance regulator gene mutations (2022-09-20),
2. 10793910 - Cystic fibrosis gene mutations (2020-10-06),
3. 10501799 - Cystic fibrosis transmembrane conductance regulator gene mutations (2019-12-10),
4. 9909183 - Cystic fibrosis transmembrane conductance regulator gene mutations (2018-03-06),
5. 9840740 - Cystic fibrosis gene mutations (2017-12-12),
6. 9410203 - Cystic fibrosis transmembrane conductance regulator gene mutations (2016-08-09),
7. 9228237 - Cystic fibrosis gene mutations (2016-01-05),
8. 8753817 - Cystic fibrosis transmembrane conductance regulator gene mutations (2014-06-17),
9. 8460871 - Cystic fibrosis gene mutations (2013-06-11),
10. 8338578 - Cystic fibrosis gene mutations (2012-12-25),
11. 8124345 - Cystic fibrosis transmembrane conductance regulator gene mutations (2012-02-28),
12. 8076078 - Cystic fibrosis gene mutations (2011-12-13),
13. 7820388 - Cystic fibrosis transmembrane conductance regulator gene mutations (2010-10-26),
14. 7803548 - Methods for diagnosing cystic fibrosis (2010-09-28),
15. 7794937 - Cystic fibrosis transmembrane conductance regulator gene mutations (2010-09-14),

Title: Franklin Quan: Innovator in Cystic Fibrosis Research

Introduction

Franklin Quan is a notable inventor based in Rancho Santa Margarita, CA (US). He has made significant contributions to the field of genetics, particularly in relation to cystic fibrosis. With a total of 15 patents to his name, Quan's work has advanced the understanding and detection of genetic mutations associated with this condition.

Latest Patents

Among his latest patents, Quan has developed innovative methods related to cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations. His inventions provide novel mutations of the CFTR gene that are linked to cystic fibrosis and related conditions. Additionally, he has created probes for detecting these mutant sequences. His methods also include identifying whether an individual possesses a genotype containing one or more mutations in the CFTR gene.

Career Highlights

Franklin Quan is currently associated with Quest Diagnostics Investments, Inc., where he continues to push the boundaries of genetic research. His work has not only contributed to scientific knowledge but has also paved the way for potential advancements in medical diagnostics and treatments for cystic fibrosis.

Collaborations

Throughout his career, Quan has collaborated with esteemed colleagues, including Matthew J McGinniss and Arlene M Buller. These partnerships have further enriched his research and innovation efforts.

Conclusion

Franklin Quan stands out as a key figure in the field of cystic fibrosis research, with a strong portfolio of patents that reflect his dedication to improving genetic understanding and patient outcomes. His contributions are vital in the ongoing fight against cystic fibrosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…